Climacteric syndrome product titles
Russian titles on prevention and therapy of climacteric syndrome, and on alternative therapy literature reviews, name pineal-peptide product approaches including Pineamine in school-adjacent writing.
identity
sequence
Glu · Asp · Arg
Key takeaways
- Pineamine is the registered drug-form label tied to the pinealon tripeptide (Glu-Asp-Arg, EDR) line in school and clinical writing.
- Mapped clinical-adjacent titles include climacteric-syndrome therapy and case reports of primary hypogonadism after COVID-19 framed with Pineamine.
- Dermatology mesotherapy titles with epiphyseal peptides sit in the wider pineal-peptide neighbourhood.
What it is
Pineamine is treated here as the commercial pinealon-line product. Identity plate uses the EDR string shared with pinealon. Identity plate uses EDR to match the featured pinealon dossier.
Corpus text cites a multicentre double-blind climacteric-syndrome RCT framing (Prilepskaya 2016) and later endocrine case observations.
We keep a separate secondary page because product-named Russian titles differ from the featured pinealon experimental map.
What the literature describes
Themed chapters drawn only from papers already mapped on this dossier. Archive map. No medical advice.
Post-COVID hypogonadism case neighbourhood
Case-report titles describe successful treatment framing of primary hypogonadism after COVID-19 with Pineamine. Archive map of published case language only.
Epiphyseal peptide mesotherapy adjacency
A title on mesotherapy with epiphyseal peptides affecting skin moisture and elasticity sits in the broader pineal-peptide applied neighbourhood.
Research trail
Product-named Russian clinical-adjacent titles are the centre. Featured pinealon carries denser experimental cognitive / oxidative maps.
IPH LGA / IPH PRO protective property titles are adjacent peptide products and are kept sparingly as neighbourhood only.
Open limits
- Is every Pineamine lot chemically identical to research-grade EDR pinealon?
- Case-report hypogonadism language is not a controlled series on this page.
- Cosmetic mesotherapy claims sit outside the core climacteric map.
Russian full-text papers
- uspeshnoe lechenie pervichnogo gipogonadizma na fone perenesennoy novoy Russian full text
- uspeshnoe lechenie pervichnogo gipogonadizma na fone perenesennoy novoy Russian full text
- novoe v profilaktike i terapii klimaktericheskogo sindroma Russian full text
- izuchenie vliyaniya mezoterapii peptidami epifiza na vlazhnost i elastic Russian full text
- sovremennyy vzglyad na alternativnuyu terapiyu klimaktericheskogo sindro Russian full text
5 in corpus
Also on PubMed
No PubMed-indexed rows mapped for this entry in the current corpus.
Still open
- How should Pineamine product titles be merged or split from the pinealon dossier?
- What manufacturing definition separates Pineamine from epithalamin fraction products?
- Are long-term climacteric safety series available in open full text?
Reviewed against the archive corpora on 2026-09-19. Source-grounded. No clinical claims. Archive / history / research only. No medical advice. No dosing, synthesis, sourcing, or health claims.